<ARTICLE> 5 <LEGEND> THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONDENSED CONSOLIDATED BALANCE SHEETS, CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS REPORTED IN FORM 10-Q FOR THE PERIOD ENDED JULY 2, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CIK> 0000925054 <NAME> SPECTRIAN CORP /DE/ <MULTIPLIER> 1,000 <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> MAR-31-2001 <PERIOD-START> APR-01-2000 <PERIOD-END> JUL-02-2000 <CASH> 11,179 <SECURITIES> 31,220<F1> <RECEIVABLES> 27,748 <ALLOWANCES> 420 <INVENTORY> 34,584 <CURRENT-ASSETS> 110,473 <PP&E> 68,380 <DEPRECIATION> 49,400 <TOTAL-ASSETS> 130,721 <CURRENT-LIABILITIES> 33,108 <BONDS> 959 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 12 <OTHER-SE> 96,642 <TOTAL-LIABILITY-AND-EQUITY> 130,721 <SALES> 42,190 <TOTAL-REVENUES> 42,190 <CGS> 35,268 <TOTAL-COSTS> 35,268 <OTHER-EXPENSES> 5,601<F2> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 46 <INCOME-PRETAX> (3,788) <INCOME-TAX> 12 <INCOME-CONTINUING> (3,800) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (3,800) <EPS-BASIC> (0.35)<F3> <EPS-DILUTED> (0.35) <FN> <F1> Securities, Item 5-02(2), are net of accrued interest and unrealized gain/loss. <F2> Item consists of research and development. <F3> Item consists of basic earnings per share. </FN>